跳至主要内容
临床试验/EUCTR2010-018553-35-SE
EUCTR2010-018553-35-SE进行中(未招募)不适用

SMARTCIT - A NOVEL CITRATE BASED ANTICOAGULATION - SmartCit

Gambro Lundia AB0 个研究点开始时间: 2010年3月18日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Stable patients treated with CRRT at the study site.
  • Patients with stabile homeostasis two hours before the inclusion.
  • Patients with a well-functioning dialysis catheter.
  • Informed consent to participate in the study by the patient or the relative.
  • Patients aged 18 years or more.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • Participation in other studies during the study period which may affect the outcome of the present study.
  • Patients dependent on chronic dialysis.
  • Patients that do not reach stability two hours before the study start.
  • CRRT during less than 10 hours.
  • Patients with HIV and/or hepatitis B and C.
  • Persons under guardianship.

研究者

相似试验